Health in WPR 65 indicators covering health for WPR. IndicatorLatest Year10-yr change Rank Pertussis - number of reported cases 159,013 2025 up 359.3% 3rd Total tetanus - number of reported cases 5,464 2025 up 282.9% 6th Infant mortality rate (probability of dying between birth and age 1) 9.69 2024 down 24.5% 13th Under-five mortality rate 12.12 2024 down 25.2% 13th Maternal mortality ratio 35.42 2023 down 19.4% 10th Number of deaths among adolescents 36,886 2024 down 8.3% 11th Number of deaths among children ages 5 to 9 years 35,571 2024 down 25.3% 11th Mortality rate among children ages 5 to 9 years 1.24 2024 down 25.7% 11th Population with primary reliance on polluting fuels and technologies 176.35 2023 down 61.9% 6th Population with primary reliance on clean fuels and technologies for 508.45 2023 up 41.4% 4th Proportion of population with primary reliance on polluting fuels and 25.8% 2023 down 54.3% 8th Proportion of population with primary reliance on fuels and 23.1% 2023 down 52.9% 10th Population with primary reliance on fuels and technologies for 152.67 2023 down 61.0% 8th Prevalence of diabetes, age-standardized 11.29 2022 up 46.9% 10th Prevalence of diabetes, crude 12.94 2022 up 62.0% 8th Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 91.0% 2025 down 5.2% 5th Measles-containing-vaccine first-dose (MCV1) immunization coverage 89.0% 2025 down 5.3% 6th New HIV infections 0.1 2025 unchanged 5th BCG immunization coverage among 1-year-olds (%) 92.0% 2025 down 3.2% 4th Mean total cholesterol, crude 4.7 2018 up 2.2% 4th Mean total cholesterol, age-standardized 4.7 2018 up 2.2% 4th Mean HDL cholesterol, crude 1.3 2018 unchanged 4th Stunting numbers among children under 5 years of age (millions) 13,454 2024 down 39.1% 13th Stunting prevalence among children under 5 years of age (%) 10.2% 2024 down 8.1% 14th Overweight prevalence among children under 5 years of age (%) 8.2% 2024 up 20.6% 5th Overweight numbers among children under 5 years of age (thousands) 8,558 2024 down 17.7% 6th Adolescent mortality rate 1.11 2021 down 19.2% 10th Incidence of tuberculosis 131 2024 unchanged 7th Deaths due to tuberculosis among HIV-negative people 9.5 2024 down 5.0% 10th Domestic private health expenditure (PVT-D) as percentage of current 24.3% 2023 down 11.5% 16th Prevalence of HIV among adults aged 15 to 49 0.2% 2025 unchanged 8th Estimated number of people (all ages) living with HIV 3.10 million 2025 up 29.2% 8th Estimated antiretroviral therapy coverage among people living with HIV 71.0% 2025 up 136.7% 4th Hypertension among adults aged 30-79 years, prevalence, crude 31.2 2019 up 3.2% 14th Hypertension: diagnosis coverage among adults aged 30-79 with 52.4% 2019 up 15.6% 8th Hypertension: effective treatment coverage (controlled hypertension) 19.0% 2019 up 43.9% 7th Hypertension treatment coverage among adults aged 30-79 with 39.3% 2019 up 13.3% 8th Hypertension among adults aged 30-79 years, prevalence 29.57 2019 down 3.7% 11th Hypertension: diagnosis coverage among adults aged 30-79 with 51.2% 2019 up 11.8% 8th Number of new HIV infections 150,000 2025 down 6.2% 6th Births attended by skilled health personnel 97.6% 2025 up 0.6% 3rd Inactivated first-dose polio vaccine (IPV1) immunization coverage 90.0% 2025 up 1,025.0% 8th Low birth weight number 2,015 2020 down 17.7% 13th Concentrations of fine particulate matter 26.7 2023 down 42.8% 12th Estimated number of MDR/RR-TB incident cases 98,000 2024 down 38.8% 4th Prevalence of anaemia in children aged 6-59 months 19.4% 2019 down 5.8% 13th Number of children aged 6-59 months with anaemia 23,271 2019 down 4.6% 11th Mean hemoglobin level of children aged 6-59 months 120 2019 unchanged 3rd Hepatitis B surface antigen (HBsAg) prevalence 0.4% 2024 down 20.0% 6th Number of deaths attributed to non-communicable diseases, by type of 3.38 million 2019 up 20.7% 3rd Estimated number of malaria cases 2.45 million 2024 down 23.0% 8th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 4th Estimated number of children needing antiretroviral therapy based on 34,000 2025 down 5.6% 8th Estimated antiretroviral therapy coverage among children 45 2025 up 18.4% 8th HPV immunization coverage estimates among primary target cohort (9-14) 23.0% 2025 up 360.0% 9th Smear-positive tuberculosis treatment-success rate 94.0% 2011 up 3.3% 1st Number of indigenous P. falciparum malaria cases 209,154 2021 up 22.6% 8th Number of suspected malaria cases 6.02 million 2021 down 39.3% 8th Number of malaria positive cases by microscopy 71,342 2021 down 37.7% 10th Number of malaria suspects examined by microscopy 1.71 million 2021 down 78.5% 10th Page 1 of 2 Next →